Angion Biomedica Corp. ANGN
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| GKCC, LLC | United States of America | 0 | 702639 | 0 | 10 | 702639 | 8.4 % | 14/06/2023 |
| Yekaterina Chudnovsky | United States of America | 707164 | 0 | 707164 | 10 | 707164 | 8.4 % | 14/06/2023 |
| Access Industries Holdings LLC | 0 | 689569 | 0 | 689569 | 689569 | 7.11 % | 12/06/2023 | |
| Access Industries, LLC | 0 | 689569 | 0 | 689569 | 689569 | 7.11 % | 12/06/2023 | |
| Len Blavatnik | 0 | 689569 | 0 | 689569 | 689569 | 7.11 % | 12/06/2023 | |
| Clal Industries Ltd. | 0 | 689569 | 0 | 689569 | 689569 | 7.11 % | 12/06/2023 | |
| Access Industries Management, LLC | 0 | 689569 | 0 | 689569 | 689569 | 7.11 % | 12/06/2023 | |
| Clal Biotechnology Industries Ltd. | 689569 | 0 | 689569 | 0 | 689569 | 7.11 % | 12/06/2023 | |
| Thomas A. Satterfield, Jr. | United States of America | 147500 | 1427047 | 147500 | 1427047 | 1574547 | 5.3 % | 19/05/2022 |
| Itzhak D. Goldberg | USA | 1815121 | 0 | 1815121 | 0 | 1815121 | 6 % | 27/04/2022 |
| Jay R. Venkatesan | USA | 2892207 | 9535 | 2892207 | 10 | 2901742 | 9.3 % | 27/04/2022 |
| Vifor Pharma Ltd. | Switzerland | 0 | 1995643 | 0 | 1995643 | 1995643 | 6.7 % | 30/03/2022 |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | Switzerland | 0 | 0 | 0 | 0 | 1995643 | 6.7 % | 30/03/2022 |
| Vifor (International) Ltd. | Switzerland | 0 | 1995643 | 0 | 1995643 | 1995643 | 6.7 % | 30/03/2022 |
| EISA-ABC, LLC | DELAWARE | 1722237 | 0 | 1722237 | 0 | 1722237 | 5.7 % | 14/02/2022 |